NN
Nicholas Naclerio (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Alamar Biosciences, Inc. (ALMR). Across 1 priced purchase filing, the average 21-session return was -6.6% from execution and -6.6% from disclosure (delay-adjusted; derived). The largest single filing was $4.0M of ALMR (235,294 sh × $17.00, as filed), executed Apr 20. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-6.6%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-6.6%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.0M
shares × price, as filed
Last traded
Apr 20
Filed Apr 20
Median ADV $12.2M across their filed names
Open performance→Volume by month
Buys $4.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ALMRRecent filings
ALMRPURCHASE
Alamar Biosciences, Inc.
View filing →
$4.0M235,294 sh × $17.00
Exec Apr 20
Filed Apr 20 · 8:31 PM ET